Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05826951 · ClinicalTrials.gov registry record · Early Phase 1
Social Effects of Alcohol
A Early Phase 1 study, sponsored by University of Chicago.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 37
- Enrollment target
NCT05826951 is a Early Phase 1 study that has completed, run by University of Chicago. The registered enrollment target is 37 participants.
The verdict
NCT05826951, a Early Phase 1 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 37 participants
- Enrollment target
Study Summary
In this study the investigator will assess the effect of a moderate dose of alcohol on emotional responses and feelings of connection during a dyadic semi-structured social interaction
Interventions
- DRUG Placebo
- DRUG Alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2023-02-20 |
| Est. Completion | 2023-10-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05826951
The ClinicalTrials.gov registry entry for NCT05826951 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05826951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05826951 about?
NCT05826951 is a clinical study titled "Social Effects of Alcohol". In this study the investigator will assess the effect of a moderate dose of alcohol on emotional responses and feelings of connection during a dyadic semi-structured social interaction
What is the current status of trial NCT05826951?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 37 participants. The study started on 2023-02-20. Estimated completion is 2023-10-03.
What interventions are being tested in trial NCT05826951?
The interventions under investigation include: Placebo (DRUG), Alcohol (DRUG).
Who is sponsoring clinical trial NCT05826951?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.